Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men-Reference-Cited by-同舟云学术

Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men

Published:2015-12 Issue:1 Volume:23 Page:
ISSN:2008-2231
Container-title:DARU Journal of Pharmaceutical Sciences
language:en
Short-container-title:DARU J Pharm Sci

Author:

Amirsadri Mohammadreza^ORCID,Hassani Abbas

Funder

Isfahan University of Medical Sciences (IR)

Publisher

Springer Science and Business Media LLC

Subject

Applied Mathematics,General Mathematics

Link

http://link.springer.com/content/pdf/10.1186/s40199-015-0129-2.pdf

Reference40 articles.

1. Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(21):2307–13.

2. Alwan A. Global status report on non-communicable diseases 2010. Geneva: World Health Organization (WHO); 2011.

3. Awad A, Al-Nafisi H. Public knowledge of cardiovascular disease and its risk factors in Kuwait: a cross-sectional survey. BMC public health. 2014;14(1):1131.

4. Reiner Ž. Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol. 2013;10(8):453–64.

5. Pichandi S, Pasupathi P, Rao YY, Farook J, Ambika A, Ponnusha BS. The role of statin drugs in combating cardiovascular diseases–A review. Int J Cur Sci Res. 2011;1(2):47–56.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study;Health Science Reports;2024-07

2. Cost-Utility Analysis of Rosuvastatin (20 mg) to Prevent Cardiovascular Diseases in Iran;Advanced Biomedical Research;2024-06

3. Cost-utility analysis of add-on vericiguat for the treatment of chronic heart failure with reduced ejection fraction in China;BMC Public Health;2024-05-09

4. Level and trend of total plasma cholesterol in national and subnational of Iran: a systematic review and age-spatio-temporal analysis from 1990 to 2016;Journal of Diabetes & Metabolic Disorders;2022-05-30

5. The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review;Global Heart;2022-03-04